Let's be real here, this is a multiple phase 3 Biotech, one already commenced funded by the WHO, one due to commence in the coming days/weeks, and 2 in the planning/organising stage and we outstanding previous data, and our market cap is $50m. it is criminally undervalued. Yes a few (including me) was disappointed with the share price action after the last trial (which still garnered good results) we have been presented with the buying opportunity of a lifetime. I never expected to own any more DXB shares going into previous trial results but I've been accumulating like a mad man ever since. Unbelievable
-
- There are more pages in this discussion • 1,896 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
54.5¢ |
Change
-0.005(0.91%) |
Mkt cap ! $327.0M | |||
| Open | High | Low | Value | Volume |
| 55.0¢ | 56.0¢ | 54.0¢ | $620.0K | 1.130M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27049 | 54.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.5¢ | 49999 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| DXB (ASX) Chart |